Platinum MatrixEM

Platinum MatrixEM is a synthetic peptide based on TGF (Transforming growth factor) nano-conjugated to platinum particles. Thanks to the conjugation with platinum particles in the colloid system, this active ingredient exhibits higher bioavailability due to greater protection against skin proteases.

The unique delivery system provides high concentrations available at the fibroblast membrane receptors. It improves the selectivity, effectivity, and activity of Platinum MatrixEM boosting extracellular matrix (ECM) components production including collagen and elastin.

Platinum MatrixEM developed alongside a delivery system to play the role of cellular mediator, modulating given cellular signals to keep the skin appearance in a good shape, healthy, and young. It is a safe ingredient that successfully passed the following toxicity tests:

  • Cytotoxicity (on human fibroblasts)
  • Het Cam
  • RIPT test
  • Genotoxicity (micronucleus test)

Ingredients

Colloidal Platinum
Acetyl Tetrapeptide-17
Functions
Anti-aging
Firming
Smoothing
CAS Number(s)
7440-06-4
EINECS number(s)
231-116-1

Nanoparticles Applied to Life Sciences

  • Nanotechnology offers exceptional opportunities to design new biomedical active compounds and to create novel tools or improve existing ones.
  • Nanoparticles have been proposed as biomedical devices for a large number of applications due to their versatile character.
  • Nanoparticles may have different sizes and configurations, with tailored structural properties.

Platinum nanoparticles

  • Many current applications are limited by the quality of these nanoparticles.
  • They show useful physical properties, including unique optical properties, robustness, biocompatible, and high surface areas, making them ideal candidates for developing biomedical applications.

Bioconjugated nanoparticles

  • Proteins and peptides nanoconjugated are of particular interest, because of their inherent programmability and biological activity.
  • They have been proposed for drug delivery, cell targeting, and tissue engineering.